fda_recall · drug_recall · high

Asclemed USA Inc. — Class II recall: Duloxetine DR Capsules, 30 mg, 30 count bottles, Rx, Relabeled by: Enovachem Pha…

Event date
2026-06-10 00:00:00Z
Observed
2026-07-09 22:51:38Z
Source ID
D-0555-2026
Payload hash
7e3523fbf11a4c44229d04bf

Summary

CGMP Deviations; presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-nitroso-duloxetine, above the FDA acceptable intake limit. Status: Ongoing.

Informational only. Not legal, financial, or medical advice.